Frequently Asked Questions About ACTN


  1. What is the Autism Clinical Trials Network?
The Autism Clinical Trials Network is a network of 8-13 medical centers collaborating on clinical trials for autism. The centers in the network collaborate on a single trial with each site recruiting children for the trial (multi-site, single protocol trial). This means that recruitment goals can be met faster, decreasing the amount of time it takes to complete a trial to screen and develop new treatments. Since the sites in the network share uniform practices for data collection, assessment training, and study methods, getting studies started is also greatly expedited.


  1. When was the Autism Clinical Trials Network started?
The Autism Clinical Trials Network was developed by Cure Autism Now in late 2005 through a grant to Dr. Eric Hollander at Mount Sinai School of Medicine.


  1. Will the Autism Clinical Trials Network only study pharmaceuticals?
No. The goal of the ACTN is to do well-controlled scientific studies of viable treatments including pharmaceuticals, neutraceuticals (vitamins etc.), and behavioral treatments.


  1. How can I get a trial in my area?
Sites are added according to their commitment to do clinical trials for autism and their ability to successfully conduct trials. Families can interest their local medical center in potential trials by telling their doctor about the network.